OR WAIT null SECS
October 11, 2017
Europe updates the guideline on excipients information in labeling and packaging.
Johnson & Johnson’s Janssen Sciences Ireland UC will invest more than EUR 300 million (US$355 million) to expand manufacturing capacity for biologic medicines at its Ireland facility.
October 06, 2017
Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.
October 04, 2017
Compared to traditional drug discovery approaches, drug repurposing, repositioning, and rescue can be faster and cheaper.
October 02, 2017
Sartorius begins building a new, EUR 30-million (US$35.2 million) Cell Culture Technology Center in Ulm, Germany.
CDMOs have established strategies for handling new chemical entities with unknown biological activity.
Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.
September 27, 2017
Omya will be presenting its functionalized calcium carbonate for several applications at the show.
Solid state solutions provider Holodiag and fine chemical R&D provider Holochem join forces.